2m 2m 2m 2m 2m 2m 2m
KEROS THERAP (KROS)
NASDAQ
$10.56-$0.54 (-4.86%)
Price as of Jul 14, 2026 4:00 PM EDT- $219.7MMarket Cap
- -23.82%1-Year Change
- BiotechnologyIndustry
KEROS THERAP (KROS)
$10.56-$0.54 (-4.86%)
KROS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.10 | ||
Change | -$0.70 (-5.93%) | ||
Open | $11.78 | ||
High | $11.78 | ||
Low | $11.00 | ||
Previous Close | $11.80 | ||
Volume | 251,059 | ||
30-Day Average Volume | 352,375 | ||
1-Week Change | 0.63% | ||
1-Month Change | 9.36% | ||
1-Year Change | -23.82% | ||
3-Year Change | -72.44% | ||
5-Year Change | -72.08% | ||
Fundamentals | |||
Shares Outstanding | 19.8M | ||
Total Assets | $312.3M | ||
Market Cap | $219.7M | ||
Enterprise Value | -$61.8M | ||
Period: QTR TTM FY | |||
Revenue | $367,000.00 | ||
Net Income | -$23.7M | ||
Free Cash Flow | -$3.6M | ||
EBIT | -$23.7M | ||
EBITDA | -$23.3M | ||
Net Working Capital | $277.8M | ||
EPS | -$1.21 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | -168 | ||
P/B | 1 | ||
P/E | -9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -61 | ||
Price/Operating Cash Flow | -62 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue